[go: up one dir, main page]

AR125365A1 - Derivados de 1h-pirazol como ligandos sigma - Google Patents

Derivados de 1h-pirazol como ligandos sigma

Info

Publication number
AR125365A1
AR125365A1 ARP220100978A ARP220100978A AR125365A1 AR 125365 A1 AR125365 A1 AR 125365A1 AR P220100978 A ARP220100978 A AR P220100978A AR P220100978 A ARP220100978 A AR P220100978A AR 125365 A1 AR125365 A1 AR 125365A1
Authority
AR
Argentina
Prior art keywords
alkyl radical
unbranched
branched
hydrogen atom
heterocyclyl
Prior art date
Application number
ARP220100978A
Other languages
English (en)
Inventor
Ana Virginia Llorente-Fernndez
Carmen Almansa-Rosales
Mnica Garca-Lpez
Ute Christmann
Jose Lus Daz-Fernndez
Original Assignee
Acondicionamiento Tarrasense
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acondicionamiento Tarrasense filed Critical Acondicionamiento Tarrasense
Publication of AR125365A1 publication Critical patent/AR125365A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos derivados de 1H-pirazol de fórmula (1) como ligandos sigma que tienen una gran afinidad por los receptores sigma, especialmente el receptor sigma-1 (s1) y/o el receptor (s2), así como al proceso para su preparación, a las composiciones que los comprenden, y a su uso como medicamentos. Reivindicación 1: Un compuesto de fórmula general (1) en donde: X es un átomo de halógeno; Het es un anillo o sistema anular heterocíclico de 5 a 12 miembros opcionalmente sustituido con uno o más radicales R²; A representa -CO-B o -CH₂-B; B es uno de los siguientes restos del grupo de fórmulas (2); Rᵃ es un átomo de hidrógeno o un radical alquilo C₁₋₆ ramificado o no ramificado; R¹ es un radical alquilo C₁₋₆ ramificado o no ramificado; un radical arilo; o a anillo heteroaromático que contiene N de 5 o 6 miembros; R² es un átomo de hidrógeno, un radical alquilo C₁₋₆ ramificado o no ramificado; un radical cicloalquilo C₃₋₉, un átomo de halógeno, un radical haloalquilo C₁₋₆ o -OR²’ es R²’ un átomo de hidrógeno o un radical alquilo C₁₋₆; R³ y R⁴ representan un átomo de hidrógeno, un radical alquilo C₁₋₆ ramificado o no ramificado; o alternativamente R³ y R⁴ forman junto con el átomo al que están unidos a grupo cicloalquilo C₃₋₉; R⁵ es un átomo de hidrógeno o un radical alquilo C₁₋₆ ramificado o no ramificado; R⁶ es un radical alquilo C₁₋₆ ramificado o no ramificado; CH(R⁶’)-(CH₂)ₖ-arilo siendo R⁶’ un átomo de hidrógeno o un radical alquilo C₁₋₆; un -(CH₂)ʲ-heterociclilo o a -CH₂-CO-heterociclilo, estando el heterociclilo opcionalmente mono- o bisustituido; R⁷ es un radical alquilo C₁₋₆ ramificado o no ramificado; -CH(R⁷’)-(CH₂)ₖ-arilo siendo R⁷’ un átomo de hidrógeno o un radical alquilo C₁₋₆, estando el arilo opcionalmente mono- o bisustituido; -(CH₂)ʲ-heterociclilo; o -CH₂-CO-heterociclilo, estando el heterociclilo opcionalmente mono- o bisustituido; W¹ es -CH₂- o -O-; j es 1 o 2; k es 0 o 1; n es 0, 1 o 2; m es 1, 2 o 3; p es 1, 2 o 3; q es 1, 2 o 3; r es 1, 2 o 3; s es 1, 2 o 3; t es 0, 1 o 2; v es 1, 2, 3 o 4; w es 1, 2, 3 o 4; en donde el compuesto de fórmula (1) está opcionalmente en forma de uno de los estereoisómeros, con preferencia enantiómeros o diastereómeros, un racemato o en forma de una mezcla de al menos dos de los estereoisómeros, con preferencia enantiómeros y/o diastereómeros, en cualquier relación de mezcla, o una correspondiente sal, cocristal o profármaco del mismo, o un correspondiente solvato del mismo.
ARP220100978A 2021-04-20 2022-04-18 Derivados de 1h-pirazol como ligandos sigma AR125365A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21382338 2021-04-20

Publications (1)

Publication Number Publication Date
AR125365A1 true AR125365A1 (es) 2023-07-12

Family

ID=75625530

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220100978A AR125365A1 (es) 2021-04-20 2022-04-18 Derivados de 1h-pirazol como ligandos sigma

Country Status (5)

Country Link
US (1) US20240239781A1 (es)
EP (1) EP4326716A1 (es)
AR (1) AR125365A1 (es)
TW (1) TW202309017A (es)
WO (1) WO2022223554A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024105225A1 (en) 2022-11-18 2024-05-23 Universitat De Barcelona Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain
WO2024193737A2 (en) * 2023-12-08 2024-09-26 Hangzhou Bituokangwei Pharmaceutical Technology Co., Ltd. Compounds of sigma receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781618B1 (en) * 2004-08-27 2012-10-03 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
EP1829867A1 (en) * 2006-03-03 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Imidazole compounds having pharmaceutical activity towards the sigma receptor

Also Published As

Publication number Publication date
US20240239781A1 (en) 2024-07-18
TW202309017A (zh) 2023-03-01
EP4326716A1 (en) 2024-02-28
WO2022223554A1 (en) 2022-10-27

Similar Documents

Publication Publication Date Title
AR117139A1 (es) Derivados de piridooxazinona como inhibidores de monoacilglicerol ligasa (magl)
AR107061A1 (es) Heteroarilhidroxipirimidinonas como agonistas del receptor de apj
AR115993A2 (es) Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr)
AR119943A1 (es) Compuestos heterocíclicos
AR104884A1 (es) Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj
AR089865A1 (es) Derivados de bencimidazol e imidazopiridinas como moduladores de canales de sodio
AR091981A1 (es) Dihidropiridona p1 como inhibidores del factor xia
AR098666A1 (es) Compuestos de biarilacetamida y sus métodos de uso
AR095198A1 (es) Derivados de triazolona de piridinilo y piridinilo fusionado
AR110498A1 (es) DERIVADOS DE ISOXAZOLIL ÉTER COMO MODULADORES ALOSTÉRICOS POSITIVOS (PAM) DE RECEPTORES DE GABAA a5
AR107321A1 (es) Compuestos antiproliferativos, y sus composiciones farmacéuticas y usos
AR107042A1 (es) Inhibidores de la tirosina quinasa de bruton y métodos de su uso
AR099498A1 (es) Compuestos de triazina y su uso farmacéutico
AR125365A1 (es) Derivados de 1h-pirazol como ligandos sigma
AR121344A1 (es) Compuestos heterocíclicos fusionados y su uso como agentes para el control de plagas
AR108387A1 (es) Compuestos de tipo tetrahidropirimidodiazepina y dihidropiridodiazepina para tratar el dolor y afecciones relacionadas con el dolor
AR116400A1 (es) Compuesto de imidazopiridinona
AR128440A1 (es) Inhibidores de cinasas raf
AR120649A1 (es) Antagonistas del receptor de crf y métodos de uso
AR119140A1 (es) Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
AR111672A1 (es) Derivados heterocíclicos con sustituyentes que contienen azufre activos como plaguicidas
AR116906A1 (es) Derivados de heteroarilo bicíclico
AR117576A1 (es) Derivados de sulfinilaminobenzamida y sulfonilaminobenzamida
AR091534A1 (es) Derivados de sulfonamida y metodos de uso de los mismos para mejorar la farmacocinetica de un farmaco
AR100126A1 (es) Activadores de herg policíclicos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal